FOLQUÉ, M.M. et al. ‘Real-life’ experience in asthmatic children treated with omalizumab up to six-years follow-up. Allergologia et Immunopathologia, Singapore, v. 47, n. 4, p. 336–341, 2019. Disponível em: https://all-imm.com/index.php/aei/article/view/299.. Acesso em: 13 may. 2026.